[ad_1]
PLYMOUTH MTG., Pa., April 2, 2019 / PRNewswire / – National Cancer Control Network® (NCCN®) announced today the winners of a series of awards recognizing individuals whose significant contributions have helped to improve and facilitate the development of quality, effective, efficient and accessible health care for all. cancer in the last year.
The 2019 winners:
The outgoing chairman of the board, Dr. Eberlein, has been awarded an award from the producers council. He was applauded for his reasonable and equitable leadership approaches, his availability for advice and his focus on promoting collaboration within the larger cancer care community.
"I think this organization is unique because of two things: excellent leadership and pbadionate staff," said Dr. Eberlein. "It's a privilege to be part of NCCN's positive impact on millions of cancer patients around the world."
Another award from the Board of Producers Award was given to Dr. Tempero in recognition of her long history of contributions to the NCCN, including the Chair of the NCCN Oncology Clinical Practice Guidelines (NCCN Guidelines).®) Pancreatic Cancer Panel, member of various other panels, member of 11 committees, participation in the Policy Advisory Group and JNCCN – Journal of the National Network Against Cancer as editor since 2014.
"I'm so proud of this organization and I feel privileged to be part of it from the very beginning," said Dr. Tempero, receiving his award. "I have witnessed impressive innovations over the years during this extraordinary trip with NCCN."
Dr. Hoppe received the Rodger Winn Reward for Expert Judgment and Commitment for Excellence in Service NCCN Guidelines®. As Founding Chair of the NCCN's Hodgkin's Lymphoma Guidelines Committee and current member of two other groups, Dr. Hoppe has earned a reputation for being collegial and respectful, compbadionate, serious and state-of-the-art of preparation. The award is in memory of the NCCN's Chief Program Leader.
Dr. Kolodziej was honored as a partner in cancer care in recognition of her efforts to engage decision-makers, employers, payers and others to improve the accessibility of high quality care for cancer treatment . He described his work with NCCN as "a huge responsibility, a huge honor and one of the best parts of my career."
Jennifer Burns is a coordinator of the NCCN Clinical Information Operations Team Guidelines. She was named recipient of the Pat Daulerio year employee award by her NCCN peers. The award – which honors the memory of a long-time employee of the NCCN Meetings Service – is awarded to a dedicated staff member who exemplifies the core values of the NCCN.
"I'm so grateful to be part of the mission I believe in so much," said Burns.
About the National Cancer Control Network
The national network against cancer® (NCCN®) is a non-profit alliance of 28 leading cancer centers dedicated to patient care, research and education. NCCN is dedicated to improving and facilitating quality, effective, efficient and accessible cancer care so patients can live a better life. Through the leadership and expertise of clinical professionals from NCCN member institutions, the NCCN develops resources that provide valuable information to the many stakeholders in the health care delivery system. In defining and advancing high quality cancer care, the NCCN stresses the importance of continuous quality improvement and recognizes the importance of creating clinical practice guidelines that can be used by patients. , clinicians and other decision-makers in the health field.
The NCCN member institutions are: Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA; Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center / University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; National Medical Center of Hope City, Duarte, CA; Dana–Farber/ Brigham and Women's Cancer Center | Mbadachusetts Cancer Center of the General Hospital, Boston, MA; Duke Cancer Institute, Durham, North Carolina; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at University of Utah, Salt Lake City, UT; Fred Hutchinson / Seattle Cancer Care Alliance Cancer Research Center, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Oncology Center Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, Florida, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, Florida; the State University of Ohio Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Comprehensive Cancer Center, Buffalo, NY; Siteman Cancer Center of Barnes-Jewish Hospital and University of Washington Medicine School, St. Louis, MO; St. Jude / The Children's Research Hospital University of Tennessee Health Sciences Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama in Birmingham Comprehensive Oncology Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, California; UCSF Helen Diller Comprehensive Family Cancer Center, San Francisco, California; University of Colorado Cancer Center, Aurora, CO; University of Michigan Rogel Cancer Center, Ann Arbor, MI; the University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbon Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center / Smilow Cancer Hospital, New Haven, CT.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients. Media, visit NCCN.org/news. Follow NCCN on Twitter @NCCNnews and Facebook @ National.Comprehensive.Cancer.Network.
Media contact:
Rachel Darwin
267-622-6624
[email protected]
SOURCE Comprehensive National Cancer Network
Related Links
http://www.nccn.org
[ad_2]
Source link
